Jason Bernhard Joins LUNGevity Foundation Board
LUNGevity Foundation, a leading nonprofit focused on improving outcomes for individuals affected by lung cancer, has announced the addition of Jason Bernhard to its Board of Directors.
Expertise in Healthcare and Finance
With nearly thirty years of investment banking experience, Jason Bernhard has been instrumental in helping healthcare clients navigate complex transactions. His strategic insights and profound understanding of the healthcare industry are expected to further LUNGevity's mission.
Impact on Lung Cancer Outcomes
Expressing enthusiasm about his new role, Andrea Ferris, President and CEO of LUNGevity Foundation, noted, "We are thrilled to have Jason join the LUNGevity Board. His investment banking expertise combined with his deep knowledge in the healthcare industry and passion for impact is exactly what we need as we expand our reach and deepen our work across research, care, and advocacy."
Personal Commitment to Lung Cancer Solutions
Jason's decision to be part of the Board underscores his commitment to advancing lung cancer solutions. In his own words, "LUNGevity is doing groundbreaking work that is changing what it means to be diagnosed with lung cancer, and I am honored to join LUNGevity's Board of Directors to help accelerate the organization's efforts to make lung cancer a survivable disease."
A Cohesive Board for Transformation
LUNGevity's Board of Directors consists of diverse leaders from various sectors, including business, healthcare, law, and advocacy, all united with a common goal: transforming lung cancer perceptions and outcomes. Jason’s appointment adds to the Board’s collective expertise and strategic capability to create significant impact.
About LUNGevity Foundation
LUNGevity Foundation stands as the nation's foremost lung cancer organization, dedicated to reshaping the experience of diagnosis and living with lung cancer. The Foundation focuses on making a significant impact on the quality of life and survivorship for every individual affected by this disease, while promoting health equity and addressing disparities in care.
Innovative Approaches in Research, Advocacy, and Community Support
The organization's multifaceted approach includes:
- Research: LUNGevity employs an innovative strategy to detect lung cancer at earlier stages, advancing research for new treatments to extend and enhance quality of life for patients. They also ensure a future-driven pipeline of researchers in lung cancer.
- Advocacy: LUNGevity champions collaborations that guarantee universal access to screening, biomarker testing, and the latest treatment breakthroughs.
- Community: By educating and connecting those affected by lung cancer, LUNGevity facilitates improved access to healthcare resources, enabling them to lead healthier, longer lives.
To support its vision of a world without lung cancer, LUNGevity provides robust resources including a medically vetted website, Patient Gateways for different lung cancer types, a dedicated HELPLine for personalized assistance, survivor conferences, and tools to locate clinical trials.
Statistics on Lung Cancer in the US
Understanding the gravity of lung cancer in the United States is critical:
- Approximately 1 in 18 Americans will face a lung cancer diagnosis in their lifetime.
- This year, over 234,000 individuals in the US will be diagnosed with lung cancer, translating to a new case every 2.2 minutes.
- About 65% of new lung cancer cases are among individuals with no or minimal tobacco exposure.
- Lung cancer claims more lives than colorectal and pancreatic cancers combined.
- Survival rates improve significantly when caught early, with a 64% five-year survival rate if diagnosed before spreading.
Frequently Asked Questions
What is the role of Jason Bernhard at LUNGevity Foundation?
Jason Bernhard serves on the Board of Directors, bringing his extensive expertise in healthcare and finance to enhance the foundation's mission.
What initiatives does LUNGevity Foundation focus on?
The foundation emphasizes research, advocacy, and community support to improve lung cancer outcomes.
Why is Jason's appointment significant?
His background in investment banking and healthcare positions him to offer valuable insights that will strengthen LUNGevity's impact.
How does LUNGevity support lung cancer patients?
LUNGevity provides resources like educational websites, support lines, and access to clinical trials to aid patients in their journey.
What statistics highlight lung cancer's impact in the US?
Key statistics include the fact that 1 in 18 Americans will be diagnosed, and more lives are lost to lung cancer than to other cancers combined.
